Search Results - "Grainger, J D"

Refine Results
  1. 1
  2. 2

    High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis by Grainger, D J, Bethell, H W L

    Published in Annals of the rheumatic diseases (01-02-2002)
    “…Background: Inappropriate inflammation is a key mechanism in the development of atherosclerosis. Antibodies against components of the atherosclerotic lesion,…”
    Get full text
    Journal Article
  3. 3

    Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice by Grainger, David J, Kemp, Paul R, Liu, Alexander C, Lawn, Richard M, Metcalfe, James C

    Published in Nature (London) (11-08-1994)
    “…A HIGH concentration of serum lipoprotein(a) is a risk factor for atherosclerosis. Lipoprotein(a) consists of low-density lipoprotein with the additional…”
    Get full text
    Journal Article
  4. 4

    Transforming Growth Factor β and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis by Grainger, David J

    “…ABSTRACT—The role of the anti-inflammatory cytokine transforming growth factor β (TGF-β) in atherosclerosis has been the subject of considerable debate for a…”
    Get full text
    Journal Article
  5. 5

    Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a) by Grainger, David J., Kirschenlohr, Heide L., Metcalfe, James C., Weissberg, Peter L., Wade, David P., Lawn, Richard M.

    “…Elevated blood concentrations of lipoprotein(a) [Lp(a)] and its constituent, apolipoprotein(a) [apo(a)], constitute a major risk factor for atherosclerosis,…”
    Get full text
    Journal Article
  6. 6

    International cross-cultural validation study of the Canadian Haemophilia Outcomes: Kids' Life Assessment Tool by McCusker, P. J., Fischer, K., Holzhauer, S., Meunier, S., Altisent, C., Grainger, J. D., Blanchette, V. S., Burke, T. A., Wakefield, C., Young, N. L.

    “…Summary Health‐related quality of life (HRQoL) assessment is recognized as an important outcome in the evaluation of different therapeutic regimens for persons…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Tamoxifen: Teaching an old drug new tricks? by Grainger, David J, Metcalfe, James C

    Published in Nature medicine (01-04-1996)
    “…Tamoxifen is the most widely studied member of a class of molecules called the triphenylethylenes (TPEs). These molecules were developed by successive chemical…”
    Get full text
    Journal Article
  9. 9

    Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice by RECKLESS, J, METCALFE, J. C, GRAINGER, D. J

    Published in Circulation (New York, N.Y.) (18-03-1997)
    “…Apolipoprotein E (apo E) knockout mice develop severe vascular lipid lesions resembling human atherosclerotic plaques, irrespective of the fat content of their…”
    Get full text
    Journal Article
  10. 10

    Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF- β levels by Byrne, C.D, Wareham, N.J, Martensz, N.D, Humphries, S.E, Metcalfe, J.C, Grainger, D.J

    Published in Atherosclerosis (01-09-1998)
    “…Whether the post-prandial lipemic response is linked to potentially pro-atherogenic and/or prothrombotic changes in plasminogen activator inhibitor (PAI) and…”
    Get full text
    Journal Article
  11. 11

    Monocyte chemoattractant protein-1 but not tumor necrosis factor-α is correlated with monocyte infiltration in mouse lipid lesions by RECKLESS, J, RUBIN, E. M, VERSTUYFT, J. B, METCALFE, J. C, GRAINGER, D. J

    Published in Circulation (New York, N.Y.) (04-05-1999)
    “…Apolipoprotein (apo)(a) transgenic mice and C57BL/6 mice fed a high fat diet develop similar-sized lipid lesions, but lesions in apo(a) mice are devoid of…”
    Get full text
    Journal Article
  12. 12

    Neonatal alloimmune thrombocytopenia with significant HLA antibodies by Grainger, J D, Morrell, G, Yates, J, Deleacy, D

    “…A case of neonatal alloimmune thrombocytopenia (NAIT) secondary to human platelet antigen (HPA)-1a antibodies is reported. Additional multispecific HLA…”
    Get full text
    Journal Article
  13. 13

    Formation of a functional morphogen gradient by a passive process in tissue from the early Xenopus embryo by McDowell, N, Gurdon, J B, Grainger, D J

    “…In early development much of the cellular diversity and pattern formation of the embryo is believed to be set up by morphogens. However, for many morphogens,…”
    Get full text
    Journal Article
  14. 14

    Quality of life in immune thrombocytopenia following treatment by Grainger, John D, Young, Nancy L, Blanchette, Victor S, Klaassen, Robert J

    Published in Archives of disease in childhood (01-11-2013)
    “…Objective To determine the impact of therapy on the reported health-related quality of life (HRQoL) in children with primary immune thrombocytopenia (ITP)…”
    Get full text
    Journal Article
  15. 15

    The role of serum TGF-beta isoforms as potential markers of osteoporosis by Grainger, D J, Percival, J, Chiano, M, Spector, T D

    Published in Osteoporosis international (01-01-1999)
    “…Osteoporosis is a major public health problem characterized by low bone mineral density (BMD) that presently has no biochemical test useful for its diagnosis…”
    Get full text
    Journal Article
  16. 16

    The pan‐chemokine inhibitor NR58‐3.14.3 abolishes tumour necrosis factor‐α accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo by Reckless, Jill, Tatalick, Lauren M., Grainger, David J.

    Published in Immunology (01-06-2001)
    “…Summary Chemokines participate in the regulation of leucocyte recruitment in a wide variety of inflammatory processes, including host defence and diseases such…”
    Get full text
    Journal Article
  17. 17

    Genetic control of the circulating concentration of transforming growth factor type beta 1 by Grainger, D J, Heathcote, K, Chiano, M, Snieder, H, Kemp, PR, Metcalfe, J C, Carter, N D, Spector, T D

    Published in Human molecular genetics (01-01-1999)
    “…The concentration of transforming growth factor beta (TGF- beta ) in plasma has been correlated with the development of several diseases, including…”
    Get full text
    Journal Article
  18. 18

    Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines by Reckless, J, Grainger, D J

    Published in Biochemical journal (15-06-1999)
    “…We have identified an amino acid sequence, termed peptide 3, corresponding to amino acids 51-62 of the mature human monocyte chemoattractant protein-1 (MCP-1),…”
    Get full text
    Journal Article
  19. 19

    Transforming growth factor β decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase by GRAINGER, D. J, KEMP, P. R, WITCHELL, C. M, WEISSBERG, P. L, METCALFE, J. C

    Published in Biochemical journal (01-04-1994)
    “…Transforming growth factor beta 1 (TGF-beta 1) decreased the rate of proliferation of rat aortic vascular smooth muscle cells (VSMCs) stimulated with serum…”
    Get full text
    Journal Article
  20. 20

    Adult human aortic smooth muscle cells in culture produce active TGF-beta by Kirschenlohr, H L, Metcalfe, J C, Weissberg, P L, Grainger, D J

    Published in The American journal of physiology (01-08-1993)
    “…Vascular smooth muscle cells (VSMC) from adult human aortas proliferated in culture in response to fetal calf serum (FCS) with a population doubling time of…”
    Get full text
    Journal Article